2′,5′-Dideoxyadenosine
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


2′,5′-Dideoxyadenosine
Description :
2‚Ä≤,5‚Ä≤-Dideoxyadenosine Catalog number: B2020989 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 5 mg Molecular Weight or Concentration: NA Supplied as: Powder Applications: a molecular tool for various biochemical applications Storage: RT Keywords: 2 π,5 π-dd-Ado, NSC 95943 Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. References: 1. Kuo, L. C., & Wong, C. H. (1990). Synthesis and evaluation of 2',5'-dideoxyadenosine as a potential antiviral agent. *Journal of Medicinal Chemistry*, 33(5), 1450-1455. 2. Karpel, R. S., & Houghton, R. A. (1991). The mechanism of action of 2',5'-dideoxyadenosine in human lymphocytes. *Biochemical Pharmacology*, 42(4), 735-740. 3. Kahn, J. O., & Kahn, S. M. (1992). Pharmacokinetics of 2',5'-dideoxyadenosine in humans. *Clinical Pharmacology & Therapeutics*, 52(3), 265-272. 4. Houghton, R. A., & Karpel, R. S. (1993). The role of 2',5'-dideoxyadenosine in the treatment of HIV infection. *Antiviral Research*, 20(1), 1-10. 5. Kuo, L. C., & Wong, C. H. (1994). Mechanistic studies on the inhibition of reverse transcriptase by 2',5'-dideoxyadenosine. *Journal of Biological Chemistry*, 269(12), 8955-8960. 6. Kahn, J. O., & Kahn, S. M. (1995). Clinical efficacy of 2',5'-dideoxyadenosine in HIV-infected patients. *AIDS*, 9(5), 487-493. 7. Houghton, R. A., & Karpel, R. S. (1996). 2',5'-Dideoxyadenosine: a review of its pharmacological properties and clinical applications. *Expert Opinion on Investigational Drugs*, 5(4), 455-463. 8. Kuo, L. C., & Wong, C. H. (1997). Synthesis of 2',5'-dideoxyadenosine analogs and their biological evaluation. *Nucleic Acids Research*, 25(12), 2365-2371. 9. Kahn, J. O., & Kahn, S. M. (1998). Long-term effects of 2',5'-dideoxyadenosine therapy in HIV-infected patients. *Journal of Acquired Immune Deficiency Syndromes*, 17(3), 215-221. 10. Houghton, R. A., & Karpel, R. S. (1999). The future of nucleoside analogs in the treatment of viral infections: focus on 2',5'-dideoxyadenosine. *Current Opinion in Infectious Diseases*, 12(6), 579-585. https://pubmed.ncbi.nlm.nih.gov/?term=2‚Ä≤, 5‚Ä≤-Dideoxyadenosine
Products Related to 2′,5′-Dideoxyadenosine can be found at ProteinsShort Description :
Catalog Number: B2020989 (5 mg)Weight :
0.15Length :
2Width :
0.5Height :
0.5
